Intelligent Drug Delivery System with Blockchain, AI, and IoT Integration
Legal Citation
Summary of the Inventive Concept
A novel drug delivery system integrating a drive assembly with blockchain, AI, and IoT technologies to enhance patient safety, optimize dosages, and enable real-time monitoring and control.
Background and Problem Solved
The original patent's drive assembly and spacer for drug delivery systems have limitations in terms of tracking and verifying the delivery process, optimizing dosages, and detecting adverse reactions. The new inventive concept addresses these limitations by integrating the drive assembly with blockchain, AI, and IoT technologies to create a more powerful and connected system.
Detailed Description of the Inventive Concept
The new inventive concept combines the drive assembly with a blockchain network to track and verify the delivery process, ensuring transparency and accountability. The system also integrates with an AI-powered predictive analytics module to forecast patient responses to different dosages and adjust the drive assembly's operation accordingly. Additionally, the system incorporates IoT connectivity to remotely update the predictive analytics module with real-time patient data and enable real-time monitoring and control of the drug delivery process. The system can also utilize novel materials with enhanced biocompatibility and incorporate genomic profiling modules for personalized medicine.
Novelty and Inventive Step
The new inventive concept introduces the integration of blockchain, AI, and IoT technologies with the drive assembly, providing a novel and non-obvious solution for enhancing patient safety, optimizing dosages, and enabling real-time monitoring and control. The specific combination of these technologies and the drive assembly is not anticipated by the original patent.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include integrating the drive assembly with other technologies, such as augmented reality or 5G networks, to further enhance the system's capabilities. Variations of the system could also be designed for specific therapeutic applications, such as diabetes management or cancer treatment.
Potential Commercial Applications and Market
The new inventive concept has significant commercial potential in the pharmaceutical and healthcare industries, particularly in the areas of personalized medicine, drug delivery systems, and remote patient monitoring. The system's ability to enhance patient safety, optimize dosages, and enable real-time monitoring and control makes it an attractive solution for healthcare providers, pharmaceutical companies, and patients alike.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical device engineering, specifically drug delivery systems and automated injection technologies, requiring expertise in mechanical design, biomedical engineering, and medical device integration
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical device designer with advanced degree, 3-5 years experience in drug delivery system design, familiar with mechanical actuation, sensor technologies, and emerging digital health integration strategies
Obviousness Rationale
A PHOSITA would recognize that integrating digital technologies like blockchain, AI, and IoT with existing drug delivery drive assemblies represents a predictable extension of current medical device innovation trends. The source patent's fundamental drive assembly design provides a natural platform for adding intelligent monitoring and control features. The technical variations represent logical combinations of known technologies to enhance medical device functionality and patient safety.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,769 |
|---|---|
| Title | Drive assembly and spacer for drug delivery system |
| Assignee(s) | Becton, Dickinson and Company |